| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $316.6M | -30.4% |
| Gross Profit | $188.1M | -27.7% |
| R&D Expense | $800K | -52.9% |
| SG&A Expense | $176.2M | -32.8% |
| Operating Income | -$113.5M | +35.0% |
| Interest Expense | $24.6M | +95.5% |
| Pre-tax Income | -$142.0M | +24.9% |
| Income Tax | $3.4M | +138.2% |
| Net Income | -$145.4M | +19.3% |
| EPS (Basic) | -$64.09 | -3203.6% |
| EPS (Diluted) | -$64.09 | -3203.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.0M | +67.2% |
| Accounts Receivable | $29.8M | -24.5% |
| Inventory | $81.6M | -24.8% |
| Current Assets | $140.2M | -18.6% |
| Total Assets | $360.3M | -27.2% |
| Current Liabilities | $47.4M | -61.1% |
| Long-term Debt | $242.1M | +60.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.6M | -543.1% |
| Capital Expenditures | $4.6M | -68.3% |
| Investing Cash Flow | -$12.0M | +17.0% |
| Financing Cash Flow | $66.5M | +1919.7% |
| Free Cash Flow | -$51.2M | -1181.7% |
| $46.0M |
| -65.6% |